Increased apoptotic activity on inflammatory human placentas in spontaneous abortions during the first and second trimester of gestation: a histochemical and immunohistochemical study by Deftereou, Theodora-Eleftheria et al.
FOLIA HISTOCHEMICA
ET CYTOBIOLOGICA
Vol. 50, No. 1, 2012
pp. 118–124
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2012
10.5603/FHC.2012.0017
www.fhc.viamedica.pl
ORIGINAL STUDY
Correspondence address: M. Lambropoulou,
Histology-Embryology Medical School,
Democritus University of Thrace,
Dragana, 68100, Alexandroupolis, Greece;
tel./fax: + 30 25510 30558;
e-mail: mlambro@med.duth.gr
Increased apoptotic activity on inflammatory
human placentas in spontaneous abortions
during the first and second trimester of gestation:
a histochemical and immunohistochemical study
Theodora-Eleftheria Deftereou1, Maria Lambropoulou1, Ekaterini Chatzaki2,
Maria Koffa3, Petros Ypsilantis4, Olga Pagonopoulou5, Iordana Grammatikopoulou1,
Elias Papadopoulos1, Alexandros Papalambros1, Emmanouil Kontomanolis6,
Nikolas Papadopoulos1
1Laboratory of Histology-Embryology, Democritus University of Thrace, Greece
2Laboratory of Pharmacology, Democritus University of Thrace, Greece
3Department of Molecular Biology and Genetics, Democritus University of Thrace, Greece
4Laboratory of Experimental Surgery and Surgical Research,
Democritus University of Thrace, Greece
5Laboratory of Physiology, Democritus University of Thrace, Greece
6Department of Obstetrics and Gynecology, Democritus University of Thrace, Greece
Abstract: The aim of this study was to investigate the role of apoptotic markers on inflammatory human placen-
tas from spontaneous abortions during the first and second trimester of gestation and compare them to those
without inflammation. Paraffin-embedded specimens from 76 placentas were investigated by conventional his-
tology and immunohistochemistry using monoclonal antibodies against M30, Caspase 3, Caspase 8 and Caspase 9,
as well as the terminal deoxynucleotidyl tranferase-mediated deoxyuridine triphosphate nick end labeling meth-
od. A higher prevalence of expression of apoptotic markers (94.4%) was observed in placentas associated with
chorioamnionitis in comparison with those without inflammation. Our observations confirm that apoptosis is
strikingly prevalent in placentas diagnosed with histologic chorioamnionitis, while the inflammation induces cell
death. (Folia Histochemica et Cytobiologica 2012, Vol. 50, No. 1, 118–124)
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Introduction
Two distinct types of cell death, apoptosis and necro-
sis, have been described, based on differences at the
morphological, biochemical and molecular level [1].
Every day, 50–70 billion cells die in the human body,
due to the phenomenon of apoptosis [2]. Apoptosis
is the commonest type of programmed cell death in
eukaryotic cells and requires the activation of intrac-
ellular biochemical pathways [1]. The main charac-
teristics of this procedure are the following: cell
shrinking, changes in the cell membrane, chromatin
condensation, nuclear fragmentation, chromosomal
DNA fragmentation, creation of apoptotic bodies,
breakdown of mitochondria, and release of cyto-
chrome C [2]. The family of cysteine proteases, also
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called caspases, plays a critical role in the molecular
apoptotic pathway [1].
Apoptosis is essential in many physiological pro-
cesses, including embryonic development of tissues,
organs and limbs, and development of the nervous
system as well as the physiological tissue turn-over in
adult organs [3].
Many studies have suggested that apoptosis plays
a significant role in the development, remodeling and
aging of the placenta. For example, activation of the
Fas system is responsible for the placental villous tro-
phoblast turnover [4–6]. It has been suggested that
the rate of trophoblast apoptosis may be altered un-
der pathologic conditions [7–9]; however, no compar-
ative studies have been conducted so far. During
chorioamnionitis, the commonest condition of fetal
membrane inflammation [10], alteration in the apop-
totic index may change the balance between cell death
and cell survival, affecting placental physiological
development [11].
A panel of antigens related to apoptosis was
used in our study for a complete evaluation of the
apoptotic activity in the placental tissues. A useful
early apoptotic marker in tissues is M30, a specific
neoepitope deriving from a caspase cleavage site
within Cytokeratin 18 [12, 13], an early event in the
apoptotic process [14]. Cytokeratin 18 is a compo-
nent of cytoskeleton of the trophoblasts that are of
epithelial origin [15]. Thus, M30 has been previ-
ously suggested as a suitable marker for studying
early trophoblast apoptosis [16]. The anti-Caspase 3
antibody detects endogenous levels of full length
Caspase 3 (35 kDa) [17]. This protein has been
identified as a key mediator of apoptosis in mam-
malian cells [18], acting as a ‘henchman’ that leads
the cell to suicide [19]. Caspase 8 binds the Fas-
-associated death domain (FADD) [20] causing its
activation [21]. Caspase 8 leads also to the activa-
tion of other descending caspases, such as Caspase 9,
which prepare the cell to undergo apoptosis [20].
Another member of caspase’s family of proteins is
pro-caspase 9 [22]. Pro-caspase 9 is activated from
Apaf-1 with proteolysis to give mature Caspase 9
[23]. This molecule can activate a caspase cascade,
including caspase 3, 6 and 7 [22]. Finally, the well-
-established TUNEL method was used for detect-
ing apoptosis, identifying apoptotic cells by using
terminal deoxynucleotidyl transferase (TdT) [17,
24]. The TUNEL technique identifies cells in the
final steps of the apoptotic cascade [14]. TUNEL,
first described by Gavrieli et al. in 1992 [25], has
several advantages in apoptosis detection, such as
rapidity, increased sensitivity and discrimination of
apoptosis from necrosis [26].
In the present study, apoptosis was evaluated in
placental membranes from spontaneous abortions, di-
agnosed with chorioamnionitis, congenital disorders
or ischemia due to nuchal cord, in order to reveal dif-
ferences indicating involvement in the pathophysio-
logical process.
Material and methods
Tissue specimens. 76 placental samples from spontaneous
abortions during the first and second trimester of pregnan-
cy were used. Tissue biopsies were collected at the villous
parenchyma from both the central and the peripheral part
of each placenta. Standard pathological examination was
performed for diagnosis by hematoxylin/eosin staining.
Chorioamnionitis was diagnosed in 54 samples (Group A),
fetal congenital malformations were found in 14 samples
(Group B), and ischemia due to nuchal cord in eight cases
(Group C). The study was conducted according to the guide-
lines for the analysis of fetal cells and tissues, and was ap-
proved by the Regional Committee of Ethics.
Immunohistochemistry. The samples were formalin-fixed
(10% of phosphate buffer) and paraffin-embedded. Four
μm serial sections were cut from the blocks using a Leica
RM2030 rotary microtome (Leica Microsystems, Germa-
ny) and were mounted on slides. They were then deparaf-
finized in an oven at 80°C for 30 minutes, followed by incu-
bation in xylene and the slides were rehydrated in descend-
ing ethanol series. Endogenous peroxidase activity was
quenched by 15 minutes incubation of slides with 0.3% H2O2.
For immunohistochemistry, the biotin-streptavidin method
was applied using the Kit CHEMICON IHC Select-Immu-
noperoxidase secondary detection system (Chemicon, USA).
Slides were washed in phosphate buffer saline (PBS) for
5 minutes and then blocking reagent was added for 10 minutes.
Slides were then incubated for 60 minutes in a humidified at-
mosphere with one of the monoclonal antibodies as follows:
M30 CytoDeath (1:80 dilution in 10% Normal Rabbit Serum
(NRS)/PBS, Alexis Biochemicals, San Diego, CA, USA), anti-
Caspase 3 (1:80 dilution in 10%NRS/PBS, Cell Signaling Tech-
nology, Hitchin, UK), anti-Caspase 8 (Spring Bioscience, Pleas-
anton, Canada) and anti-Caspase 9 (Spring Bioscience, Pleas-
anton, Canada). In parallel, negative control slides were incu-
bated with 10% NRS/PBS. After washing with PBS, the
biotinylated secondary antibody was added for 10 minutes,
followed by streptavidin HRP incubation for 10 minutes. Fi-
nally, bound antibody complexes were stained for 10 min with
0.05% diaminobenzidine chromogen (DAKO, Carpinteria,
CA, USA). Finally, sections were briefly counterstained with
Mayer’s hematoxylin, mounted and examined under a Nikon
microscope of × 400 magnification. An homogenous, light
brown staining of the cytoplasm revealed positive cells.
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Terminal deoxynucleotidyl transferase-mediated deoxyuri-
dine triphosphate nick end labeling (TUNEL). TUNEL was
performed using the In Situ Death Detection kit (Roche,
Mannheim, Germany) according to the manufacturer’s in-
structions. Briefly, deparaffinized 4 μm tissue sections were
incubated with 50 μl of Label and Enzyme Solution for 60
min at 37°C in a humidified atmosphere in the dark. The
biotin-labeled cleavage sites were then detected by reac-
tion with HRP conjugated streptavidin and visualized by
diaminobenzidine chromogen. As a negative control, slides
were incubated with 50 μl Label Solution. Light brown stain-
ing of the nucleus and cytoplasm indicated positive cells.
All slides were photographed with Nikon Digital Sight
SD-SI (Nikon Corporation, Japan).
Evaluation of immunostaining. Each slide was individually
evaluated and scored in a blinded fashion by two indepen-
dent observers (M.L. and N.P.). Positivity was graded in
a four-scale system as follows 0: absent, 1: < 10%, 2:
10–50%, 3: > 50% positive cells in the total number of cells
counted per field (at least ten). Positive samples were
considered when the score was different from 0 as well
as exhibiting both morphological features of apoptosis
on light microscope (cytoplasmic fragmentation and nu-
clear condensation).
Statistical analysis. Percentages of positive tissues among
the three studied groups were compared using the chi-square
test (SPSS, v. 12). Significance was set at a p value < 0.05.
Results
The study’s specimen characteristics are summa-
rized in Table 1. Table 2 presents the incidence of
positive immunostaining for the apoptotic mark-
ers examined in the three groups. Table 3 shows
the expression levels of the apoptotic markers in
the three groups.
Immunohistochemical staining for all apoptotic
markers, Caspase 3, 8, and 9 and M30 showed cyto-
plasmic localization in syncytiotrophoblast, whereas
Caspase 3 had also cytoplasmic immunoreactivity. In
group A (chorioamnionitis), 51/54 (94.4%) of the
cases expressed all the apoptotic markers examined,
and three cases were found negative. Two of them
derived from male fetuses miscarried in the 20th and
23rd gestational week, while the third sample derived
from a female fetus aborted in the 16th week of gesta-
tion. In group B (congenital malformations), only
1/14 (7.2%) was positive for the apoptotic marker
Caspase 3, whereas all other immunohistochemical
staining was found negative. Finally, all eight placen-
tal samples from group C (ischemia) were negative
for all the apoptotic markers examined.
Statistical analysis revealed significantly higher
percentages of positive tissues in group A in compar-
ison with the other two groups (p < 0.05). Mean ex-
pression levels of Caspase 3, 8 and 9 in group A were
2.52 ± 0.88, 2.57 ± 0.86 and 2.51 ± 0.88 respectively,
and for M30 2.48 ± 0.88. TUNEL staining also con-
firmed that placental tissues from group A had sig-
nificantly increased levels of apoptotic cells; with
mean levels in TUNEL score 2.66 ± 0.77, as com-
pared to the other two groups. The TUNEL-positive
cells were found in the trophoblast and stromal cells.
Increased TUNEL-positive staining in syncytiotro-
phoblast layer was shown in the placenta in group A
(Figures 1, 2).
Table 1. Aborted embryo characteristics
Group Number of cases Embryo sex          Cause of embryonic death
                                      Gestational age
Total 9th–17th week 18th–24th week Male Female
A 54 18 36 31 23 Chorioamnionitis
B 14 3 11 8 6 Congenital disorders
C 8 1 7 5 3 Ischemia due to nuchal cord
Table 2. Incidence of positive apoptotic marker immunostaining in the placenta of spontaneously aborted embryos
Diagnosis Group n Incidence (%) of apoptotic marker positive immunostaining
Caspase 3 Caspase 8 Caspase 9 M30 TUNEL
Histologic chorioamnionitis A 54 94.4 94.4 94.4 94.4 94.4
Congenital disorders B 14 7.2 0 0 0 0
Ischemic death C 8 0 0 0 0 0
p < 0.05 group A vs. B and C
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Discussion
It is well known that apoptosis is a nodal cellular phe-
nomenon with a significant role for the orderly oper-
ation of the multicellular organism as a whole [27,
28]. In the apoptotic process, a number of molecules
are involved directly or indirectly, e.g. FasL/FasR,
TNF-a/TNFR1, Bcl-2 family, and as a result several
cellular activities are also influenced [29, 30]. The pla-
centa’s growth rate, structure and cellular composi-
tion are modified upon implantation of the develop-
ing embryo into the maternal endometrium during
pregnancy [31]. Apoptosis plays a critical role during
placental evolution [32]. In normal term placentas,
Smith et al. [7] found an apoptotic rate of 0.05%. Our
results show differential apoptotic activity in placen-
tas from spontaneous abortions due to different caus-
es in the first and second trimesters of pregnancy.
Indeed, we report the expression of multiple apop-
totic markers in placentas from spontaneously abort-
ed fetuses, diagnosed for chorioamnionitis, congeni-
tal malformation or ischemia due to nuchal cord.
Immunohistochemical evaluation showed high apo-
ptotic levels in the cases diagnosed with inflamma-
tion, contrary to the other tissues where apoptosis was
absent.
Chorioamnionitis is an inflammation of the chori-
on and amnion that can be caused by a bacterial in-
fection ascending into the uterus from the mother’s
urogenital tract [33]. Specifically, the infection can
begin in the vagina, anus or rectum and move up and
into the uterus where the fetus is located [33]. Ac-
cording to Salafia et al. [34], histologic chorioamnion-
itis is described as the presence of severe inflamma-
tory changes on examination of membrane roll and
chorionic plate of the placenta. Chorioamnionitis is
observed in approximately 10% of all births [35] and
its severity is classified in grades from 1 to 3 [36]. Acute
chorioamnionitis is recognized by the intense infil-
tration of neutrophils that expand from the subchori-
onic space throughout the chorion [37].
Our results showed that the prevalence of all apo-
ptotic markers was substantially higher in the sam-
ples observed with chorioamnionitis compared to
those from abortions attributed to congenital malfor-
mations or ischemia, where the apoptotic expression
was almost absent. These results indicate a strong
relationship between inflammation and apoptosis in
the placental tissue.
Our results are in accordance with other studies
addressing the relation of apoptosis to inflammation
in the placental tissue [11, 14, 21, 38, 39]. Tanir et al.
[38] showed that the presence of infection was found
to be highly associated with rupture of membrane
(ROM) in placentas (53.8%), a condition closely re-
lated to apoptosis. Fortunato et al. [40] suggested that
the main underlying factor leading to apoptosis in
placentas from ROM cases was a lipopolysaccharide
Table 3. Expression levels in apoptotic markers in chorioamnionitis and congenital disorders
Apoptotic marker Groups Expression level
0 1 2 3
Caspase 3 Chorioamnionitis 3 5 8 38
(n = 54) (5.55%) (9.26%) (14.82) (70.37%)
Congenital disorders 13 1 0 0
(n = 14) (92.8%) (7.2%) (0%) (0%)
Caspase 8 Chorioamnionitis 3 4 6 41
(n = 54) (5.55%) (7.41%) (11.11%) (75.93%)
Congenital disorders 14 0 0        0
(n = 14) (100%) (0%) (0%) (0%)
Caspase 9 Chorioamnionitis 3 5 7 39
(n = 54) (5.55%) (9.26%) (12.97%) (72.22%)
Congenital disorders 14 0 0 0
(n = 14) (100%) (0%) (0%) (0%)
M30 Chorioamnionitis 3 5 9 37
(n = 54) (5.55%) (9.26%) (16.67%) (68.52%)
Congenital disorders 14 0 0 0
(n = 14) (100%) (0%) (0%) (0%)
TUNEL Chorioamnionitis 3 1 7 43
(n = 54) (5.55%) (1.85%) (12.97%) (79.63%)
Congenital disorders 14 0 0 0
(n = 14) (100%) (0%) (0%) (0%)
122 T-E Deftereou et al.
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2012
10.5603/FHC.2012.0017
www.fhc.viamedica.pl
from gram-negative bacterial infections. These li-
popolysaccharides stimulate TNF-a (tumor necrosis
factor a), inducing an intracellular apoptotic caspase
pathway. Using TUNEL, Murtha et al. [11] observed
that chorion laeve from subjects with histologically
verified chorioamnionitis had significantly more ap-
Figure 1. Representative micrographs immunostaining for Caspase 3 (A), Caspase 8 (B), M30 (C), and TUNEL (D)
in placental tissue diagnosed with chorioamnionitis. Positive trophoblast cells are marked with arrows (original magnification × 400)
Figure 2. Representative micrographs immunostaining for Caspase 3 (A), Caspase 8 (B), M30 (C), and TUNEL (D)
(congenital disorders and ischemia, original magnification × 400)
A B
C D
A B
C D
Caspase 3
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Caspase 8
TUNEL
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optotic nuclei compared to those without infection.
Recently, George et al. [41] provided TUNEL data
supporting the hypothesis that inflammation acceler-
ates cell death and destruction of the chorion.
Generally, when cells undergo apoptosis, there is
no inflammatory response; however, when peritoneal
macrophages and dendritic cells incur Fas-mediated
apoptosis, cytokines and neutrophil chemotactic fac-
tors are released [42]. This implies that in the case of
inflammation, certain cellular molecules are secret-
ed in order to activate the programmed cell death
[37]. A remarkable feature of chorioamnionitis is the
activation of the placental immune cells, leading to
the release of inflammatory molecules into the pla-
cental microenvironment, such as cytokines [37]. This
evokes the infiltration of the chorion, amnion and
placental villi by neutrophils, a hallmark of chorio-
amnionitis [37]. The proinflammatory cytokines have
cytotoxic activity to trophoblasts, inducing their apo-
ptosis [43].
A possible mechanism for inflammation in chorio-
amnionitis involves the apoptotic pathway of FasL/
/Fas [44]. The bacterial infection may activate placen-
tal immune cells to produce cytokines, which in turn
induces Fas-mediated apoptosis of trophoblasts. Thus,
as more cytokines and chemotactic factors are re-
leased, the inflammatory process is amplified [37].
Based on the results of this study, we conclude that
the presence of histologic chorioamnionitis in the pla-
centa from spontaneous abortions during the first and
second trimester is relevant with high apoptotic ac-
tivity. It is well understood that the inflammatory pro-
cess affects the balance between survival and cell
death inducing apoptosis. As placental tissues play
an important role in the maintenance of pregnancy,
inflammation-related apoptosis can significantly con-
tribute to the mechanism leading to spontaneous
abortion.
It will be of interest to further investigate the role
of the different apoptotic pathways in this context, as
well as in relation to the diversity of the bacterial in-
fection leading to spontaneous abortions.
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